Found 5 matching trials
Perioperative Encobini in BRAFV600 Mutant Stage III (B/C/D) or Oligometastatic Stage IV Melanoma
PHASE2A two-arm, randomised trial investigating the response of encorafenib and b...
Location
Addenbrooke's Hospital
Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma.
PHASE1To evaluate the safety, tolerability and efficacy of LEE011 and LGX818 when...
Location
University of Colorado Dept of Oncology
Intermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 Mutations
PHASE2This phase II trial studies intermittent dosing of BRAF inhibitor LGX818 (e...
Location
Jonsson Comprehensive Cancer Center
PF-07284892 in Participants With Advanced Solid Tumors
PHASE1The purpose of this first-in-patient, open label study is to determine the ...
Location
Mayo Clinic in Arizona - Phoenix
A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma
PHASE1CLGX818X2101 is a first-time in-human, phase I study to establish the maxim...
Location
H Lee Moffitt Cancer Center and Research Institute